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Previews2005), indicating that binding of E6 to PDZ
domains might be implicated in the devel-
opment of cervical cancer. Remarkably,
E6 was found to bind to PTPN3, a very
close paralog of PTPN4, via the PDZ
domain of PTPN3 (Jing et al., 2007).
Indeed, the last five residues at the
C terminus of HPV18 E6 read ‘‘RETQV,’’
which is a very close sequence to the
last five residues of the optimized PTPN4-
binding cell killing peptide of Babault et al.
(2011) (RETEV). It will be very interesting
to investigate whether the cell-pene-
trating PTPN4-binding peptides devel-
oped by Babault et al. interfere with the
interaction of HPV E6 with PTPN3 and/orpromote the induction of apoptosis of
HPV-positive cancer cell lines, such as
HeLa, SiHa, or CaSki.REFERENCES
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Our understanding of poly-ADP-ribosylation as a posttranslational modification was limited by the lack of
structural information on poly-ADP-ribose (PAR) hydrolysing enzymes. A recent study in Nature (Slade
et al., 2011) reports the structure of PAR glycohydrolase (PARG), revealing unexpected similarity to the
ubiquitous ADP-ribose-binding macrodomains.Poly-ADP-ribosylation is a reversible post-
translational modification (PTM) that oc-
curs mostly in response to cellular stress
(e.g., DNA strand breaks) and is catalyzed
by members of the PAR polymerase
(PARP) family. Utilizing NAD+ as a sub-
strate, PARP enzymes form complex
branched PAR polymers covalently at-
tached to target proteins, such as nuclear
histones. The best-characterized member
of the PARP family is PARP-1, which cata-
lyzes more than 90% of the PAR syn-
thesis that occurs rapidly in response to
different types DNA damage. Although still
lacking a complete understanding, the
mechanistic and functional aspects of
PARsynthesis havebeenextensively char-
acterized, and structural information for all
domains of PARP-1 is available (Langelier
et al., 2011). Much progress is also being
made with regard to how PAR functions incells and how this PTM is recognized by
various cellular machineries.
Although PARP-1 and PARylation have
been known for over forty years, it is the
discoveries in recent years of macrodo-
mains and PAR-binding zinc fingers
(PBZ) as readout modules for ADP-ribose
(Karras et al., 2005; Ahel et al., 2008) that
has ignited interest in the field and given
us badly needed new tools for this elusive
PTM. Crystal structures of several macro-
domain proteins bound to ADP-ribose
provide atomic insight into how these
globular protein modules appear de-
signed to recognize ADP-ribose moieties
deep within their extended nucleotide
binding pocket. Further, NMR structures
of PBZ domains have been highlighted
an alternativemechanism of PAR recogni-
tion (Karras et al., 2005; Timinszky et al.,
2009; Eustermann et al., 2010).In sharp contrast, we had no structural
insight into the mechanism of how
PAR chains can be rapidly removed
from the modified proteins. While it was
known that PARG enzymes catalyze the
breakdown of PAR into individual ADP-
ribose moieties and that the PARG null
mutation causes lethality in mouse
embryos (Koh et al., 2004), underscoring
the physiological importance of PAR
catabolism, no structures on PARG ex-
isted. There was also uncertainty in the
community as to whether PARG may be
able to cleave off terminal ADP-ribose
moieties (exo-), ‘‘internal’’ O-glycosidic
bonds (endo-activity), and/or also remove
the ADP-ribose moiety from mono-ADP-
ribosylated side chains (Koch-Nolte
et al., 2009).
In a recent Nature report, Slade et al.
(2011) were able to gain high-resolution2011 Elsevier Ltd All rights reserved 1351
Figure 1. Comparison of T. curvata PARG in Complex with ADP-
Ribose with Three Representative Macrodomain Structures
Cartoon view of (A) PARG with ADP-ribose (PDB ID 3SIG), (B) macroH2A1.1
with ADP-ribose (PDB ID 3IID), (C) MacroD1 (PDB ID 2X47), and (D) YmdB
(PDB ID 1SPV) showing the core a-b-a sandwich fold typical of macrodomains
in blue. Extended noncanonical structural features are shown in pale green.
ADP-ribose is shown in yellow. The signature GGG-X6-8-QEE loop in PARG
and the Gly-rich loops typical in macrodomains are shown in red. The
conserved GVFG stretches are shown in orange.
Structure
Previewsstructural information on the
enzymes that catalyze PAR
breakdown reactions by de-
termining the crystal structure
and the mechanism of catal-
ysis of a bacterial enzyme
with PARG activity. Similar to
its anabolic counterpart
PARP-1, PARG orthologs
have been described for al-
most all eukaryotic organisms.
Certain filamentous fungi and
bacteria, however, lack ob-
vious PARG orthologs. Now,
Slade et al. (2011) reveal the
existence of a domain termed
DUF2263 that is a distant rela-
tive of the eukaryotic PARG
fold. While the structure and
enzymatic analysis leaves
open a few questions, the
report by Slade et al. resolves
issues about PARG specificity
and reveals a striking struc-
tural similarity to the con-
served and widespread family
of ADP-ribose-bindingmacro-
domainmodules (Karras et al.,
2005;Kustatscheretal., 2005),
as was initially predicted for
human PARG using sensitive
fold recognition algorithms
(unpublished research by
Fernando Bazan cited in
Koch-Nolte et al., 2009). Sladeet al. (2011) use biochemical assays to
identify PAR glycohydrolase activity of
these ‘‘PARG-like’’ domains from a
number of organisms. Consistently, over-
expression experiments with human
PARP-1 and the bacterial PARG enzymes
in yeast confirm that the newly identified
PARG-like enzymes suppress PAR
formation.
The presence of proteins with PARG
activity in bacteria is puzzling. Clearly,
the new data reveal that enzymes capable
of degrading PAR appeared earlier than
previously thought, raising questions on
the evolutionary origin(s) of PARylation
pathways. The function of PAR metabo-
lism in bacteria might be related to DNA
damage responses, as illustrated by the
upregulation of the PARG homolog in the
radiation resistant bacteria Deinococcus
radiodurans (Liu et al., 2003). Further
work is needed to shed light on the nature
of PAR and/or ADP-ribose-related meta-
bolism in bacteria.1352 Structure 19, October 12, 2011 ª2011 EThe structure of PARG extends the list
of the known functions of macrodomains
with those of a glycohydrolase and is
proof of the versatility of this simple fold,
which typically consists of a six-strand
b sheet sandwiched by five characteristic
a helices (Figure 1). E. coli YmdB and
humanMacroH2A1.1, for example, repre-
sent such canonical macrodomains.
Human MacroD1 has a 55 amino acid
a-helical extension at the N terminus and
now Thermomonospora curvata PARG
shows yet another type of N-terminal
helical extension. Several macrodomain
proteins not only efficiently, rapidly, and
transiently recognize PARylated proteins,
mono-ADP-ribose, phospho-ADP-ribose,
and the Sir2/sirtuin NAD metabolite
O-acetyl-ADP-ribose, but they have also
been reported to possess catalytic
activity (Timinszky et al., 2009; Karras
et al., 2005; Kustatscher et al., 2005;
Chen et al., 2011). This raises a question
if the known crystal structures can pro-lsevier Ltd All rights reservedvide insight into the functional
versatility of macrodomains.
The catalytic activity of
PARG strongly depends on
the two Glu residues in the
GGG-X6-8-QEE motif (E114
and E115 in T. curvata
PARG) (Figure 1A, red loop).
Although both Glu residues
are essential for activity, only
E115 is proposed, based on
structural evidence, to be
directly involved in the catal-
ysis. E115 and an ordered
water molecule are in an ideal
position to cleave an ADP-
ribose moiety via the for-
mation of an oxocarbenium
intermediate, providing a
plausible mechanism for the
hydrolytic mechanism of PAR
breakdown.
Comparing PARG to
MacroD1, one of the enzymes
recently shown to efficiently
deacetylate O-acetyl-ADP-
ribose, we find the close
structural and evolutionary
relationship between macro
and PARG domains. For
example, the residues inMac-
roD1 that are proposed to
catalyze the acetyl hydrolysis
(N174, D184) are located in
the vicinity of a Gly-rich loop,which in macrodomains forms the rim of
the ADP-ribose cavity analogous to the
signature GGG-X6-8-QEE loop in PARG
(Figures 1A and 1C, red). Furthermore,
the diphosphate-binding loop, which
flanks the other side of the ADP-ribose-
binding cavity, is highly conserved
between PARG and macrodomains
(GVFG motif, orange loops in Figure 1). In
both PARG-ADP-ribose and macrodo-
main-ADP-ribose structures, ADP-ribose
is recognized in an almost identical
manner. The presence of a 20-OH-linked
ADP-ribose group on ribose would be
prohibited without major structural rear-
rangements, providing us with evidence
that PARG is an exo- rather than an endo-
glycohydrolase (Figures 1Aand1B). Slade
et al. (2011) also show that the enzyme is
not able to efficiently remove the last
ADP-ribose moiety. For DUF2263, this
answered a few long awaited questions,
but how similar are T. curvata and meta-
zoan PARG likely to be? It is expected
Structure
Previewsthat human PARG domains will closely
resemble and therefore also have a fold
based on the macrodomain. The key
sequence motifs mentioned above are
highly conserved and a homology search
for human PARG (http://www.sbg.bio.ic.
ac.uk/phyre/) indeed confirms the close
relationship to T. curvata PARG.
Important questions remain open. Only
a subset of themacrodomains are catalyt-
ically active and some are not even
capable of binding ADP-ribose or related
nucleotide ligands (Kustatscher et al.,
2005). For example, the ligands for the
histone variants macroH2A1.2 and mac-
roH2A2 remain completely unknown,
despite the high conversation of these
histones across vertebrate evolution. On
the issue of PAR degradation as a regula-
tory posttranslational modification, the
question of which enzyme(s) may specifi-
cally remove the ‘‘final’’ ADP-ribose
moiety from posttranslationally modified
proteins remains open. The hunt for such
enzymes and for physiological PARP-
family targets is made more complex by
the fact that there is evidence to support
both glutamate and lysine residues askey ADP-ribose acceptors. There can be
much confidence, however, that such
open questions will soon be addressed.
In conclusion, after more than forty
years of research into ADP-ribosylation
signaling, the paper by Slade et al.
(2011) has provided us with detailed
structural insight into PARG enzymes,
a plausible PAR degradation mechanism,
and revealed a surprising relation to the
macrodomain module. As the ADP-ribo-
sylation field shifts into a higher gear
with this and other recent progress, the
stage looks set for further surprises. Other
macrodomains in disguise may abound,
promising to reveal new molecular and
physiological roles for this nucleic acid
with signaling functions.REFERENCES
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Tail-anchored (TA) membrane proteins perform essential cellular functions. They are posttranslationally
inserted into the endoplasmic reticulum (ER) membrane by interaction of the Get3 chaperone with the
Get1/2 receptor. Two independent structural and functional analyses of the Get3/receptor complex by Stefer
et al. and Mariappan et al. now provide insights into TA protein insertion.In the textbooks, insertion of membrane
proteins into the ER is mediated by the
universally conserved signal-recognition
particle (SRP), which relies on the pres-
ence of an N-terminal signal sequence
(Grudnik et al., 2009). In eukaryotes, how-
ever, about 5% of all membrane proteins,
including the SNARE or Bcl-2 family pro-
teins, carry their targeting signal within a
single transmembrane domain present at
their C terminus and are therefore termedtail-anchored (TA) proteins. They are sub-
ject to the recently identified GET (guided
entry of TA proteins) pathway (reviewed in
Simpson et al., 2010). The GET machin-
ery comprises at least five components
(Get1–5) thatmediate the threemain steps
of TA protein insertion: Get4/5 assisted
loading of the Get3 ATPase with a TA pro-
tein, docking of the Get3/TA protein com-
plex to the Get1/2 receptor at the ER, and
subsequent insertion. The Get3 ATPaseforms the core of the GET machinery,
and a series of Get3 crystal structures
suggests that the Get3 dimer oscillates
between an ‘‘open’’ and a ‘‘closed’’ state
by a nucleotide-dependent rotation of
the two subunits (Simpson et al., 2010).
While the dimer is clamped together at
the bottom by a zinc ion, the TA protein
is expected to bind to a hydrophobic
pocket on top of the ATPase domain in
the TA protein binding domain (TABD),2011 Elsevier Ltd All rights reserved 1353
